Amgen Inc
Officers & Directors
Mr. Kevin W. Sharer, age 63, has served as a director of the Company since November
1992. Mr. Sharer has been the Company’s Chief Executive Officer since May
2000 and has also been Chairman of the Board of Directors since January 2001.
Effective as of May 23, 2012, Mr. Sharer will step down as CEO of the Company.
Mr. Sharer will remain as Chairman of the Board of Directors until December 31,
2012, at which time he will retire from the Board and the Company. From May 2000
to May 2010, Mr. Sharer served as the Company’s President and Chief Operating
Officer. From October 1992 to May 2000, Mr. Sharer served as President and Chief
Operating Officer of the Company. From April 1989 to October 1992, Mr. Sharer
was President of the Business Markets Division of MCI Communications Corporation.
From February 1984 to March 1989, Mr. Sharer held numerous executive capacities
at General Electric Company (GE). Mr. Sharer is a director of Chevron Corporation
and Northrop Grumman Corporation. He is Chairman of the Board of the Los Angeles
County Museum of Natural History.
Mr. David W. Beier, age 63, became Senior Vice President, Global Government and
Corporate Affairs in March 2008. He joined the Company in 2003 as Senior Vice
President, Global Government Affairs. Previously, Mr. Beier was a partner with
the law firm of Hogan and Hartson in Washington, D.C. From 1998 to early 2001,
Mr. Beier served as Chief Domestic Policy Advisor to the Vice President of the
United States. He also held positions as Vice President of Government Affairs
and Public Policy for Genentech and staff counsel in the U.S. House of Representatives.
Dr. Fabrizio Bonanni, age 65, became Executive Vice President, Operations in August
2007. He served as Senior Vice President, Manufacturing of the Company from 2004
to August 2007. Dr. Bonanni joined the Company in 1999 as Senior Vice President,
Quality and Compliance, and in June 2001, he also became the Corporate Compliance
Officer. Previously, Dr. Bonanni held various management positions at Baxter International,
Inc. from 1974 to 1999, including positions as Corporate Vice President, Regulatory
and Clinical Affairs and Corporate Vice President, Quality System.
Mr. Robert A. Bradway, age 49, has served as a director of the Company since October
2011. Mr. Bradway has been the Company’s President and Chief Operating Officer
since May 2010 and will succeed to the role of Chief Executive Officer in May
2012. Mr. Bradway joined the Company in 2006 as Vice President, Operations Strategy
and served as Executive Vice President and Chief Financial Officer from April
2007 to May 2010. Prior to joining the Company, he was a Managing Director at
Morgan Stanley in London where he had responsibility for the firm’s banking
department and corporate finance activities in Europe and focused on healthcare.
Dr. Sean E. Harper, age 49, became Executive Vice President, Research and Development
in February 2012. Dr. Harper joined the Company in 2002, and has held leadership
roles in early development, medical sciences and global regulatory and safety.
Dr. Harper served as Senior Vice President, Global Development and Corporate Chief
Medical Officer from March 2007 to February 2012. Prior to joining the Company,
Dr. Harper worked for five years at Merck Research Laboratories.
Mr. Anthony C. Hooper, age 57, became Executive Vice President, Global Commercial
Operations in October 2011. From March 2010 to October 2011, Mr. Hooper was Senior
Vice President, Commercial Operations and President, U.S., Japan and Intercontinental
of BMS, a pharmaceutical company. From January 2009 to March 2010, Mr. Hooper
was President, Americas of BMS. From January 2004 to January 2009, Mr. Hooper
was President, U.S. Pharmaceuticals, Worldwide Pharmaceuticals Group, a division
of BMS. Prior to this, Mr. Hooper held various senior leadership positions at
BMS. In his roles at BMS, Mr. Hooper led commercial operations in mature and emerging
markets. Prior to joining BMS, Mr. Hooper was Assistant Vice President of Global
Marketing for Wyeth Laboratories.
Mr. Brian McNamee, age 55, became Senior Vice President, Human Resources in June
2001. From November 1999 to June 2001, Mr. McNamee served as Vice President of
Human Resources at Dell Computer Corp. From 1998 to 1999, Mr. McNamee served as
Senior Vice President, Human Resources for the National Broadcasting Corporation,
a division of GE. From July 1988 to November 1999, Mr. McNamee held human resources
positions at GE.
Mr. Jonathan M. Peacock, age 53, became Executive Vice President and Chief Financial
Officer in September 2010. Prior to joining Amgen, Mr. Peacock served as Chief
Financial and Administration Officer of Novartis Pharmaceuticals AG, a healthcare
company based in Switzerland, beginning in 2005. From 1998 to 2005, Mr. Peacock
was a partner at McKinsey and Co., where he co-led the European Corporate Finance
Practice. Mr. Peacock was also a partner at Price Waterhouse in London and New
York from 1993 to 1998.
Ms. Anna S. Richo, age 51, became Senior Vice President and Chief Compliance Officer
in June 2008. From December 2003 to June 2008, Ms. Richo served as Vice President,
Law. Prior to Amgen, she spent 12 years at Baxter Healthcare Corporation in roles
of increasing responsibility in law, including Vice President, Law, for Baxter’s
BioScience Division. Also, for more than five years, Ms. Richo served on the Board
of Directors of Cytyc Corporation and was a member of the Audit and Finance Committees.
Mr. David J. Scott, age 59, became Senior Vice President, General Counsel and
Secretary in March 2004. From May 1999 to February 2004, Mr. Scott served as Senior
Vice President and General Counsel of Medtronic, Inc. and also as Secretary from
January 2000. From December 1997 to April 1999, Mr. Scott served as General Counsel
of London-based United Distillers & Vintners. Mr. Scott also served in executive
roles at Grand Metropolitan plc and RJR Nabisco, Inc., and was an attorney in
private practice.
Amgen Inc currently has 13000 employees.
|
|
